Dashboard
Manage Tickers

DAWN


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

earnings-scheduled-for-november-4-2025
Earnings Scheduled For November 4, 2025
11/04/2025 11:12:08

super-micro-computer-posts-downbeat-q4-results-joins-personalis-snap-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session
Super Micro Computer Posts Downbeat Q4 Res...
08/06/2025 12:11:55

hc-wainwright--co-maintains-buy-on-day-one-biopharmaceutical-lowers-price-target-to-25
HC Wainwright & Co. Maintains Buy on Day O...
08/06/2025 11:24:39

HC Wainwright & Co. analyst Andrew S. Fein maintains Day One Biopharmaceutical (NASDAQ:DAWN) with a Buy and lowers the p...

needham-maintains-buy-on-day-one-biopharmaceutical-lowers-price-target-to-16
Needham Maintains Buy on Day One Biopharma...
08/06/2025 09:39:05

Needham analyst Ami Fadia maintains Day One Biopharmaceutical (NASDAQ:DAWN) with a Buy and lowers the price target from $18 ...

why-astera-labs-shares-are-trading-higher-by-over-17-here-are-20-stocks-moving-premarket
Why Astera Labs Shares Are Trading Higher ...
08/06/2025 09:35:31

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
08/05/2025 21:07:20

day-one-biopharmaceutical-q2-eps-029-beats-035-estimate-sales-33908m-miss-35926m-estimate
Day One Biopharmaceutical Q2 EPS $(0.29) B...
08/05/2025 20:01:12

Day One Biopharmaceutical (NASDAQ:DAWN) reported quarterly losses of $(0.29) per share which beat the analyst consensus estimat...

Core News & Articles
Earnings Scheduled For August 5, 2025
08/05/2025 08:32:54

needham-maintains-buy-on-day-one-biopharmaceutical-lowers-price-target-to-27
Needham Maintains Buy on Day One Biopharma...
05/07/2025 12:19:17

Needham analyst Ami Fadia maintains Day One Biopharmaceutical (NASDAQ:DAWN) with a Buy and lowers the price target from $30 ...

day-one-biopharmaceutical-q1-eps-035-beats-044-estimate-sales-3076m-beat-3024m-estimate
Day One Biopharmaceutical Q1 EPS $(0.35) B...
05/06/2025 20:04:54

Day One Biopharmaceutical (NASDAQ:DAWN) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimat...

Core News & Articles
Earnings Scheduled For May 6, 2025
05/06/2025 08:32:41

hc-wainwright--co-reiterates-buy-on-day-one-biopharmaceutical-maintains-36-price-target
HC Wainwright & Co. Reiterates Buy on Day ...
04/03/2025 10:43:21

HC Wainwright & Co. analyst Andres Maldonado reiterates Day One Biopharmaceutical (NASDAQ:DAWN) with a Buy and maintains...

goldman-sachs-maintains-buy-on-day-one-biopharmaceutical-lowers-price-target-to-27
Goldman Sachs Maintains Buy on Day One Bio...
03/25/2025 15:38:11

Goldman Sachs analyst Andrea Tan maintains Day One Biopharmaceutical (NASDAQ:DAWN) with a Buy and lowers the price target fr...

jp-morgan-maintains-overweight-on-day-one-biopharmaceutical-lowers-price-target-to-34
JP Morgan Maintains Overweight on Day One ...
03/05/2025 14:57:57

JP Morgan analyst Anupam Rama maintains Day One Biopharmaceutical (NASDAQ:DAWN) with a Overweight and lowers the price targe...

wedbush-reiterates-outperform-on-day-one-biopharmaceutical-maintains-32-price-target
Wedbush Reiterates Outperform on Day One B...
02/26/2025 15:47:03

Wedbush analyst Robert Driscoll reiterates Day One Biopharmaceutical (NASDAQ:DAWN) with a Outperform and maintains $32 price...

hc-wainwright--co-maintains-buy-on-day-one-biopharmaceutical-lowers-price-target-to-36
HC Wainwright & Co. Maintains Buy on Day O...
02/26/2025 12:26:17

HC Wainwright & Co. analyst Andres Maldonado maintains Day One Biopharmaceutical (NASDAQ:DAWN) with a Buy and lowers the...

needham-reiterates-buy-on-day-one-biopharmaceutical-maintains-32-price-target
Needham Reiterates Buy on Day One Biopharm...
02/26/2025 11:13:45

Needham analyst Ami Fadia reiterates Day One Biopharmaceutical (NASDAQ:DAWN) with a Buy and maintains $32 price target.

day-one-biopharmaceutical-q4-gaap-eps-069-misses-036-estimate-sales-2921m-beat-2779m-estimate
Day One Biopharmaceutical Q4 GAAP EPS $(0....
02/25/2025 21:23:05

Day One Biopharmaceutical (NASDAQ:DAWN) reported quarterly losses of $(0.69) per share which missed the analyst consensus estim...

earnings-scheduled-for-february-25-2025
Earnings Scheduled For February 25, 2025
02/25/2025 08:32:24

goldman-sachs-maintains-buy-on-day-one-biopharmaceutical-lowers-price-target-to-43
Goldman Sachs Maintains Buy on Day One Bio...
02/10/2025 17:01:21

Goldman Sachs analyst Andrea Tan maintains Day One Biopharmaceutical (NASDAQ:DAWN) with a Buy and lowers the price target fr...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION